TABLE 4-10 R&D Expenditures and Sales of All U.S. Pharmaceuticals and of the Biologics Component

Year

R&D Expenditures

Sales

Total R&D/Total Sales (percent)

Biologics R&D/Biologics Sales (percent)

 

Pharmaceuticals (millions of $)

Biologics (millions of $)

Biologics Component (percent)

Pharmaceuticals (millions of $)

Biologics (millions of $)

Biologics Component (percent)

 

 

1973

644

25.7

4.0

5,122

138.3

2.7

12.57

18.58

1974

726

32.7

4.5

5,657

152.7

2.7

12.83

21.41

1975

829

24.9

3.0

6,412

160.3

2.5

12.92

15.53

1976

903

28.0

3.1

7,117

121.0

1.7

12.69

23.14

1977

984

30.5

3.1

7,705

169.5

2.2

12.77

17.99

1978

1,089

34.9

3.2

8,424

235.9

2.8

12.93

14.79

1979

1,243

31.0

2.5

9,240

240.2

2.6

13.45

12.91

1980

1,455

45.1

3.1

11,091

244.0

2.2

13.12

18.48

1981

1,765

42.3

2.4

13,000

468.0

3.6

13.58

9.04

1982

2,158

49.6

2.3

15,394

538.8

3.5

14.02

9.21

1983

2,538

53.3

2.1

16,565

 

 

15.32

 

1984

2,843

 

 

 

 

 

 

 

1985

3,234

84.1

2.6

21,205

 

 

15.25

 

1986

3,721

85.6

2.3

24,032

 

 

15.48

 

1987

4,342

121.6

2.8

27,019

 

 

16.07

 

1988

5,051

207.1

4.1

29,692

 

 

17.01

 

1989

5,824

273.7

4.7

33,469

 

 

17.40

 

1990

6,446

 

 

 

 

 

 

 

1991

7,276

 

 

 

 

 

 

 

NOTE: All data are for members of the Pharmaceutical Manufacturers Association. R&D expenditures are for company-financed R&D for ethical pharmaceuticals and biologics for human use. Biologics include bacterial and viral vaccines, antigens, antitoxins, toxoids, and allogenic extracts as well as sera, plasma, and other blood derivatives for human use.

a Sales of biologics are unavailable for 1983 to present.

SOURCE: PMA Survey of Members, Annual Survey Report; Timothy Brogan, personal communication, Pharmaceutical Manufacturers Association, 1992.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement